Espansione Group receives CE Mark approval for eye-light® photobiomodulation device
The flagship, light-based technology has received approval for applications in the anterior and posterior segments
Global leaders in cataract run the Olympic gauntlet of surgery
Surgeons shared practical pearls in a “Cataract Olympiad"
The 16th European Glaucoma Society Congress convenes in Dublin
This year’s meeting will take place in Ireland’s technology and business hub
Monitoring glaucoma progression rate to preserve patients’ vision
Three approaches to examination give a comprehensive overview
European Commission grants Marketing Authorisation for bevacizumab gamma
The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)
Dopavision announces topline results for MyopiaX trial for slowing paedatric myopia progression
The light-based therapy functions using a virtual reality headset
Racing against microbial keratitis
Challenging choices force ophthalmologists to weigh long-term outcomes
Role of ferroptosis in bacterial keratitis
Inhibiting ferroptosis could be crucial to reducing inflammation
Post hoc analysis shows how pegcetacoplan may impact RPE atrophy
Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy
Professor Noemi Lois awarded Edinburgh King James IV Professorship by The Royal College of Surgeons
Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress
United States FDA approves two aflibercept 2 mg biosimilars
The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen
Predicting visual acuity with a machine learning system
For decoding biomarkers, a multistage system is just the beginning
The evolving role of vitreosurgical simulators in surgical training
Need for accuracy results in optimisation of training for novice surgeons
For younger patients with mid-range myopia, consider phakic IOLs
The implantable lenses can offer an advantage over laser surgery
The good, the bad and the maybe in ocular gene therapies
Promising innovations are not one-size-fits-all
Outlook Therapeutics submits UK Marketing Authorisation Application for wet AMD treatment
The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March
ARVO 2024: Trial design and increased accuracy of meibomian gland morphology measurements
At the 2024 ARVO meeting, Andrew D. Pucker, OD, PhD, presented a paper on measuring meibomian gland morphology
ARVO 2024: Mutation agnostic optogenetic programme demonstrates possible treatment for patients with severe retinal degeneration
Allen Ho, MD, presented on the 12-month results of an mutation agnostic optogenetic programme at the ARVO 2024 meeting
Going beyond the clinical setting in ophthalmic mentorship
Three leaders in glaucoma research, retina care and refractive surgery share their expertise
Keratometry and total keratometry values are similar in healthy eyes
Astigmatic values differed between K and TK readings
ARVO 2024: Predicting the efficacy of myopia control methods using 1-year data
At this year's ARVO meeting, the Eye Care Network got a glimpse at the future of paediatric myopia control research
Reconfiguring treatment goals for paediatric myopia around ocular development
Considering ages and stages of myopia progression in a therapeutic timeline
ARVO 2024: President-elect SriniVas Sadda, MD, shares his strategies for engaging vision experts worldwide
Incoming ARVO president SriniVas R. Sadda, MD, discussed major challenges in vision science research and how annual meetings inspire innovation in ophthalmology
ARVO 2024: Reliability of contact specular microscopy in the corneal endothelium
Elias Kahan speaks about his ARVO poster, "Contact specular microscopy reliably images the same location of the corneal epithelium"
ARVO 2024: Non-invasive testing could use tear film to screen for changes in Huntington Disease
The mutant huntingtin protein in tear fluid may have the potential to serve as an early marker of changes in Huntington disease
ARVO 2024: Exploring multi-ingredient oral supplements for alleviating symptoms of dry eye disease
At this year's ARVO meeting, Neda Gioia, OD, discussed the increasing patient burden of dry eye disease
ARVO 2024: Evaluating a lipid-containing eye drop for dry eye disease
Eric Donnenfeld, MD, discusses the clinical evaluation of Blink Triple Care artificial tears ahead of the 2024 ARVO meeting
ARVO 2024: Dry eye patient selection following post-hoc analysis of GOBI and MOJAVE trials
John Sheppard, MD, MSc, FACs, discusses the unique biochemical traits of perfluorohexyloctane for eye dry disease and meibomian gland dysfunction
ARVO 2024: Assessing melanocortin receptors and inflammation in the ocular space
Paul Kayne, PhD gave an onsite overview of his poster at the 2024 ARVO meeting
ARVO 2024: Imaging provides insight into the metabolic aspects of glaucoma development
Osamah Saeedi, MD, MS, discusses his poster presentation from the ARVO Imaging in the Eye conference
